Repertaxin Struktur

Repertaxin

Bezeichnung:Repertaxin

CAS-Nr266359-83-5

Englisch Name:Repertaxin

CBNumberCB82628350

SummenformelC14H21NO3S

Molgewicht283.39

MOL-Datei266359-83-5.mol

Repertaxin physikalisch-chemischer Eigenschaften

Schmelzpunkt	103-105℃
Dichte	1.137±0.06 g/cm3(Predicted)
storage temp.	Sealed in dry,Room Temperature
Löslichkeit	Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 25 mg/ml)
pka	4.28±0.40(Predicted)
Aggregatzustand	solid
Farbe	White
Optische Aktivität	[α]/D -80 to -90°, c =1.0 in ethanol
Stabilität	Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.

Gefahreninformationscode (GHS)

Repertaxin Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
Reparixin (CAS 266359-83-5) is a noncompetitive allosteric inhibitor of IL-8 (CXCL8) activation of CXCR1 and CXCR2 chemokine receptors (IC50?= 1 and 100 nM, respectively). It blocks a number of activities related to IL-8 signaling, including leukocyte recruitment (IC50?= 1 nM) without affecting receptor activation induced by other CXCR1 and CXCR2 agonists.1?In spontaneously hypertensive rats, 5 mg/kg reparixin administered daily for three weeks was shown to reduce blood pressure by inhibiting hypertension-related mediators.2?It attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord.3?Reparixin blockade (100 nM) of CXCR1 has also been used to deplete a cancer stem cell population in human breast cancer cell lines?in vitro.4
Verwenden
Prevention of delayed graft function in solid organ transplant (CXCL8 inhibitor).
Verwenden
Reparixin is an inhibitor of CXCR1 and CXCR2 chemokine receptors. Functions as an agent that blocks a range of activities including leukocyte recruitment and IL-8 signaling.
Definition
ChEBI: Reparixin is a monoterpenoid.
Einzelnachweise
1) Bertini?et al.?(2004),?Non-competitive allosteric inhibitors of the inflammatory cytokine receptors CXCR1 and CXCR2: prevention of reperfusion injury; Proc. Natl. Acad. Sci. USA,?101?11791 2) Kim?et al. (2011),?Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats; Biol. Pharm. Bull.,?34?120 3) Gorio?et al.?(2007),?Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord; J. Pharmacol. Exp. Ther.,?322?973 4) Ginestier?et al.?(2010),?CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts; J. Clin. Invest.,?120?485

Repertaxin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Send Inquriy